Cargando…

CLINICAL CHARACTERISTICS AND OUTCOMES OF COVID-19 PATIENTS WITH MYOCARDIAL INJURY: ONE-YEAR EXPERIENCE IN VANCOUVER, CANADA

BACKGROUND: The coronavirus 2019 (COVID-19) pandemic has caused unparalleled public health crisis worldwide. Myocardial injury in acutely ill hospitalized COVID-19 patients was associated with higher mortality and worse clinical outcomes. However, Canadian data on COVID-19 and myocardial injury is n...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, C, Choi, J, Saw, J, Samuel, R, Grewal, T, Parolis, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523085/
http://dx.doi.org/10.1016/j.cjca.2021.07.049
_version_ 1784585221567414272
author Yang, C
Choi, J
Saw, J
Samuel, R
Grewal, T
Parolis, J
author_facet Yang, C
Choi, J
Saw, J
Samuel, R
Grewal, T
Parolis, J
author_sort Yang, C
collection PubMed
description BACKGROUND: The coronavirus 2019 (COVID-19) pandemic has caused unparalleled public health crisis worldwide. Myocardial injury in acutely ill hospitalized COVID-19 patients was associated with higher mortality and worse clinical outcomes. However, Canadian data on COVID-19 and myocardial injury is not available, and this is paramount to inform quality of care and direct efficient resource allocation. METHODS AND RESULTS: We conducted a retrospective study of patients with COVID-19 with myocardial injury admitted to two quaternary hospitals in British Columbia; Vancouver General Hospital between March 2020 – February, 2021 and St. Paul's Hospital between April – December, 2020. Myocardial injury was defined as troponin elevation greater than 99% upper limit of normal (normal troponin-I < 0.05 ng/L, troponin-T < 9 ng/L in female, < 14 ng/L in male) on admission or during hospitalization. Baseline demographics, laboratory results, and in-hospital outcomes were collected. The study was approved by our institutional research board. We included 494 COVID-19 patients in the study. The mean age was 63.4 years, and 58.9% were men. The prevalence of myocardial injury was 37.2%. Sixty-five patients (13.2%) died during hospitalization, of which 49 (9.9%) had myocardial injury. Patients with myocardial injury were more likely to require mechanical ventilation (31.1% vs. 12.1%, p < 0.001) and inotropic support (2.7% vs. 0.0%, p < 0.01). They had higher mortality (26.8% vs. 5.2%, p < 0.001), shock (11.5% vs. 1.0%, p < 0.00), cardiac arrest (15.3% vs. 2.9%, p < 0.001), heart failure (7.1% vs. 0.3%, p < 0.001), stroke (2.7% vs. 0.3%, p=0.019), and significantly longer length of hospitalization (23.7 vs. 13.6 days, p < 0.001) than patients without myocardial injury. Four myocardial injury patients were diagnosed with ST-elevation or non-ST elevation MI. CONCLUSION: Myocardial injury was frequent amongst hospitalized COVID-19 patients in British Columbia, and was associated with worse clinical outcomes and increased length of hospital stay.
format Online
Article
Text
id pubmed-8523085
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-85230852021-10-20 CLINICAL CHARACTERISTICS AND OUTCOMES OF COVID-19 PATIENTS WITH MYOCARDIAL INJURY: ONE-YEAR EXPERIENCE IN VANCOUVER, CANADA Yang, C Choi, J Saw, J Samuel, R Grewal, T Parolis, J Can J Cardiol P030 BACKGROUND: The coronavirus 2019 (COVID-19) pandemic has caused unparalleled public health crisis worldwide. Myocardial injury in acutely ill hospitalized COVID-19 patients was associated with higher mortality and worse clinical outcomes. However, Canadian data on COVID-19 and myocardial injury is not available, and this is paramount to inform quality of care and direct efficient resource allocation. METHODS AND RESULTS: We conducted a retrospective study of patients with COVID-19 with myocardial injury admitted to two quaternary hospitals in British Columbia; Vancouver General Hospital between March 2020 – February, 2021 and St. Paul's Hospital between April – December, 2020. Myocardial injury was defined as troponin elevation greater than 99% upper limit of normal (normal troponin-I < 0.05 ng/L, troponin-T < 9 ng/L in female, < 14 ng/L in male) on admission or during hospitalization. Baseline demographics, laboratory results, and in-hospital outcomes were collected. The study was approved by our institutional research board. We included 494 COVID-19 patients in the study. The mean age was 63.4 years, and 58.9% were men. The prevalence of myocardial injury was 37.2%. Sixty-five patients (13.2%) died during hospitalization, of which 49 (9.9%) had myocardial injury. Patients with myocardial injury were more likely to require mechanical ventilation (31.1% vs. 12.1%, p < 0.001) and inotropic support (2.7% vs. 0.0%, p < 0.01). They had higher mortality (26.8% vs. 5.2%, p < 0.001), shock (11.5% vs. 1.0%, p < 0.00), cardiac arrest (15.3% vs. 2.9%, p < 0.001), heart failure (7.1% vs. 0.3%, p < 0.001), stroke (2.7% vs. 0.3%, p=0.019), and significantly longer length of hospitalization (23.7 vs. 13.6 days, p < 0.001) than patients without myocardial injury. Four myocardial injury patients were diagnosed with ST-elevation or non-ST elevation MI. CONCLUSION: Myocardial injury was frequent amongst hospitalized COVID-19 patients in British Columbia, and was associated with worse clinical outcomes and increased length of hospital stay. Published by Elsevier Inc. 2021-10 2021-10-18 /pmc/articles/PMC8523085/ http://dx.doi.org/10.1016/j.cjca.2021.07.049 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle P030
Yang, C
Choi, J
Saw, J
Samuel, R
Grewal, T
Parolis, J
CLINICAL CHARACTERISTICS AND OUTCOMES OF COVID-19 PATIENTS WITH MYOCARDIAL INJURY: ONE-YEAR EXPERIENCE IN VANCOUVER, CANADA
title CLINICAL CHARACTERISTICS AND OUTCOMES OF COVID-19 PATIENTS WITH MYOCARDIAL INJURY: ONE-YEAR EXPERIENCE IN VANCOUVER, CANADA
title_full CLINICAL CHARACTERISTICS AND OUTCOMES OF COVID-19 PATIENTS WITH MYOCARDIAL INJURY: ONE-YEAR EXPERIENCE IN VANCOUVER, CANADA
title_fullStr CLINICAL CHARACTERISTICS AND OUTCOMES OF COVID-19 PATIENTS WITH MYOCARDIAL INJURY: ONE-YEAR EXPERIENCE IN VANCOUVER, CANADA
title_full_unstemmed CLINICAL CHARACTERISTICS AND OUTCOMES OF COVID-19 PATIENTS WITH MYOCARDIAL INJURY: ONE-YEAR EXPERIENCE IN VANCOUVER, CANADA
title_short CLINICAL CHARACTERISTICS AND OUTCOMES OF COVID-19 PATIENTS WITH MYOCARDIAL INJURY: ONE-YEAR EXPERIENCE IN VANCOUVER, CANADA
title_sort clinical characteristics and outcomes of covid-19 patients with myocardial injury: one-year experience in vancouver, canada
topic P030
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523085/
http://dx.doi.org/10.1016/j.cjca.2021.07.049
work_keys_str_mv AT yangc clinicalcharacteristicsandoutcomesofcovid19patientswithmyocardialinjuryoneyearexperienceinvancouvercanada
AT choij clinicalcharacteristicsandoutcomesofcovid19patientswithmyocardialinjuryoneyearexperienceinvancouvercanada
AT sawj clinicalcharacteristicsandoutcomesofcovid19patientswithmyocardialinjuryoneyearexperienceinvancouvercanada
AT samuelr clinicalcharacteristicsandoutcomesofcovid19patientswithmyocardialinjuryoneyearexperienceinvancouvercanada
AT grewalt clinicalcharacteristicsandoutcomesofcovid19patientswithmyocardialinjuryoneyearexperienceinvancouvercanada
AT parolisj clinicalcharacteristicsandoutcomesofcovid19patientswithmyocardialinjuryoneyearexperienceinvancouvercanada